Cellulitis

Bottom Line
  • Empiric coverage for MRSA is not required given the low rates of MRSA in the community and at KGH.
  • Intravenous therapy is required for systemic infection or rapidly progressing erythema.
  • The presence of “bilateral” cellulitis suggests an etiology other than infection.

Empiric Therapy